0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

Oral Acyclovir and Intralesional Interferon Injections for Treatment of Giant Pyogenic Granuloma–Like Lesions in an Immunocompromised Patient With Human Orf FREE

Menglong Ran, MD1,2; Mingyang Lee, MD, MS1,2; Jie Gong, PhD1,2,3; Zhimiao Lin, MD1,2; Ruoyu Li, MD1,2,3
[+] Author Affiliations
1Department of Dermatology, Peking University First Hospital, Beijing, China
2Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China
3Research Center for Medical Mycology, Peking University, Beijing, China
JAMA Dermatol. 2015;151(9):1032-1034. doi:10.1001/jamadermatol.2015.0760.
Text Size: A A A
Published online

Orf is a zoonotic infection caused by a parapoxvirus and is widespread in sheep and goats. Human orf, characterized by self-limiting purulent skin lesions at inoculation sites, is caused by contact with infected animals. In immunocompromised patients, orf often exhibits atypical, multifocal, persistent, giant lesions, making treatment frustrating.

REPORT OF A CASE

A man in his 40s presented with a 3-month history of 3 rapidly enlarging lesions that developed at the sites of injuries sustained while working with livestock. He had a history of transplantation 3 years earlier and had been taking tacrolimus since that time to avoid rejection. Physical examination revealed 2 exophytic large granulomas on his left thumb (Figure 1A) and forearm (2 × 3 and 3 × 5 cm, respectively) and a red exudative papule on his right forefinger. Histopathologic analysis revealed acanthosis with ballooning degeneration and eosinophilic inclusions (Figure 2A and B) in some keratinocytes as well as abundant blood vessels in the dermis. Transmission electron microscopy showed numerous oval viral particles in degenerated keratinocytes (Figure 2C). Polymerase chain reaction analysis using specific primers described previously1 followed by Sanger sequencing confirmed the diagnosis of human orf.

Place holder to copy figure label and caption
Figure 1.
Clinical Images of the Thumb Lesion Before and After Treatment

A, A 2 × 3-cm erosive tumor with bloody crusts developed at the site of an accidental syringe stick on the left thumb. B, Complete resolution of the giant orf tumor after combination treatment with oral acyclovir and intralesional interferon injections left black dots, scars, and crusts.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Histological Features of Biopsy Specimens From Left Thumb Lesion

A, Acanthosis and ballooning degeneration of keratinocytes and abundant blood vessels with edema and inflammation seen in the dermis (hematoxylin-eosin, original magnification ×100). B, Eosinophilic virus inclusions (arrowheads) found in degenerated keratinocytes (hematoxylin-eosin, original magnification ×400). C, Transmission electron microscopy shows a large amount of viral particles with major axes over 200 nm found in degenerated keratinocytes.

Graphic Jump Location

The patient was treated with oral acyclovir, 400 mg every 6 hours, and intralesional interferon alpha-2b injection, 1.5 million IU/wk. Two weeks after the commencement of treatment, remarkable shrinkage of lesions with reduced hemorrhage and exudation were noted. Weekly interferon injections were discontinued at the end of week 6, when all the lesions were resolved, leaving small black scars with crusts (Figure 1B). Acyclovir was given for a further 3 weeks to prevent viral relapse, which has often been documented in orf infection in immunocompromised patients.2 At 1-year follow-up, there were no signs of relapse.

DISCUSSION

Human orf is a self-limiting disease and usually subsides within 4 to 12 weeks with scarring.3 However, immunocompromised patients are prone to large and refractory orf tumors.25 Such rare, atypical forms of orf are frequently associated with the use of posttransplantation immunosuppressants,3,6 such as glucocorticoids, cyclosporine, and tacrolimus. Clinically, the patients often present with pyogenic granuloma like lesions,3,6 as noted in our case.

Treatment of giant orf tumors in immunocompromised individuals typically relies on surgical excision, which is often followed by rapid postoperative recurrence.2,3 To spare patients unnecessary surgeries, a number of topical medications such as idoxuridine,3 cidofovir,4 and imiquimod5,6 have been documented. Among them, imiquimod cream alone or as an adjuvant with surgery appears to have lower recurrence rates, making it the most commonly used topical treatment in recent years.

In the present case, our new, nonsurgical, combined antiviral strategy was based on the following information: (1) Both idoxuridine and acyclovir are nucleoside analogues that competitively inhibit viral DNA polymerases; thus they are used as common antiviral drugs for treatment of different herpesvirus infections. (2) Interferon alpha, in addition to its well-known antiviral properties, has strong antiproliferative and antiangiogenic effects by downregulating vascular endothelial growth factor, which makes it a strong candidate to treat our patient with highly vascularized orf tumors. In view of this information, we started treating the patient with the experimental combined therapy of oral acyclovir and intralesional interferon alpha-2b.

This strategy is minimally invasive and has mild adverse effects. Our patient experienced only low-grade (<38°C), manageable fever at the first night of each injection. Furthermore, the combined therapy took only 6 weeks to completely clear the lesions—one of the shortest recovery periods reported to date (compare several recent imiquimod cream studies, which have reported complete resolution within 6-17 weeks5,6). Nevertheless, further follow-up will be important to find possible signs of orf relapse. More studies are required to confirm the actual effectiveness of acyclovir to inhibit orf virus.

ARTICLE INFORMATION

Corresponding Author: Zhimiao Lin, MD, Department of Dermatology, Peking University First Hospital, 8 Xishiku St, Xicheng District, Beijing 100034, China (zhimiaolin@bjmu.edu.cn).

Published Online: May 6, 2015. doi:10.1001/jamadermatol.2015.0760.

Author Contributions: Authors Ran and Lee contributed equally to this report.

Conflict of Interest Disclosures: None reported.

Funding/Support: This work was supported by grant YETP0069 from the Beijing Higher Education Young Elite Teacher Project (Dr Lin).

Role of the Funder/Sponsor: The Beijing Higher Education Young Elite Teacher Project had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Additional Contributions: We are grateful to the patient for participation in this study.

REFERENCES

Torfason  EG, Gunadóttir  S.  Polymerase chain reaction for laboratory diagnosis of orf virus infections. J Clin Virol. 2002;24(1-2):79-84.
PubMed   |  Link to Article
Tan  ST, Blake  GB, Chambers  S.  Recurrent orf in an immunocompromised host. Br J Plast Surg. 1991;44(6):465-467.
PubMed   |  Link to Article
Hosamani  M, Scagliarini  A, Bhanuprakash  V, McInnes  CJ, Singh  RK.  Orf: an update on current research and future perspectives. Expert Rev Anti Infect Ther. 2009;7(7):879-893.
PubMed   |  Link to Article
Geerinck  K, Lukito  G, Snoeck  R,  et al.  A case of human orf in an immunocompromised patient treated successfully with cidofovir cream. J Med Virol. 2001;64(4):543-549.
PubMed   |  Link to Article
Rørdam  OM, Grimstad  Ø, Spigset  O, Ryggen  K.  Giant orf with prolonged recovery in a patient with psoriatic arthritis treated with etanercept. Acta Derm Venereol. 2013;93(4):487-488.
PubMed   |  Link to Article
Zaharia  D, Kanitakis  J, Pouteil-Noble  C, Euvrard  S.  Rapidly growing orf in a renal transplant recipient: favourable outcome with reduction of immunosuppression and imiquimod. Transpl Int. 2010;23(10):e62-e64.
PubMed   |  Link to Article

Figures

Place holder to copy figure label and caption
Figure 1.
Clinical Images of the Thumb Lesion Before and After Treatment

A, A 2 × 3-cm erosive tumor with bloody crusts developed at the site of an accidental syringe stick on the left thumb. B, Complete resolution of the giant orf tumor after combination treatment with oral acyclovir and intralesional interferon injections left black dots, scars, and crusts.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Histological Features of Biopsy Specimens From Left Thumb Lesion

A, Acanthosis and ballooning degeneration of keratinocytes and abundant blood vessels with edema and inflammation seen in the dermis (hematoxylin-eosin, original magnification ×100). B, Eosinophilic virus inclusions (arrowheads) found in degenerated keratinocytes (hematoxylin-eosin, original magnification ×400). C, Transmission electron microscopy shows a large amount of viral particles with major axes over 200 nm found in degenerated keratinocytes.

Graphic Jump Location

Tables

References

Torfason  EG, Gunadóttir  S.  Polymerase chain reaction for laboratory diagnosis of orf virus infections. J Clin Virol. 2002;24(1-2):79-84.
PubMed   |  Link to Article
Tan  ST, Blake  GB, Chambers  S.  Recurrent orf in an immunocompromised host. Br J Plast Surg. 1991;44(6):465-467.
PubMed   |  Link to Article
Hosamani  M, Scagliarini  A, Bhanuprakash  V, McInnes  CJ, Singh  RK.  Orf: an update on current research and future perspectives. Expert Rev Anti Infect Ther. 2009;7(7):879-893.
PubMed   |  Link to Article
Geerinck  K, Lukito  G, Snoeck  R,  et al.  A case of human orf in an immunocompromised patient treated successfully with cidofovir cream. J Med Virol. 2001;64(4):543-549.
PubMed   |  Link to Article
Rørdam  OM, Grimstad  Ø, Spigset  O, Ryggen  K.  Giant orf with prolonged recovery in a patient with psoriatic arthritis treated with etanercept. Acta Derm Venereol. 2013;93(4):487-488.
PubMed   |  Link to Article
Zaharia  D, Kanitakis  J, Pouteil-Noble  C, Euvrard  S.  Rapidly growing orf in a renal transplant recipient: favourable outcome with reduction of immunosuppression and imiquimod. Transpl Int. 2010;23(10):e62-e64.
PubMed   |  Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

418 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs